Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial

Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial

Abstract Chemo-immunotherapy is the current first-line treatment for patients with extensive-stage small cell lung cancer (ES-SCLC), but survival benefits are modest. We aimed to evaluate the safety, antitumor activity and biomarkers of first-line camrelizumab and apatinib plus chemotherapy in untre...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ming Liu, Guihuan Qiu, Wenhui Guan, Xie Xiaohong, Xinqing Lin, Zhanhong Xie, Jiexia Zhang, Yinyin Qin, Haijian Du, Xin Chen, Yu Deng, Shiyue Li, Jincun Zhao, Chengzhi Zhou
Médium: Artigo
Jazyk:angličtina
Vydáno: 2025
On-line přístup:https://doi.org/10.1038/s41392-025-02153-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1038/s41392-025-02153-7

Podobné jednotky